Ramipril 5mgTablet
Cardiac & Anti-Coagulant

Ramipril 5mg

Ramipril

Long-acting ACE inhibitor with demonstrated cardiovascular risk reduction benefits across hypertension, post-MI left ventricular dysfunction, chronic heart failure, and diabetic nephropathy, supported by landmark HOPE and REIN trial data. Available in four strengths from Sanofi and Cipla for stepwise titration, exported globally as a cornerstone RAAS agent in both primary and secondary cardiovascular prevention protocols.

Strengths

1.25mg / 2.5mg / 5mg / 10mg

Packing

10 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Ramipril 1.25mg / 2.5mg / 5mg / 10mg
Dosage Form
Tablet
Available Strengths
1.25mg / 2.5mg / 5mg / 10mg
Packing
10 tablets/strip
Route of Administration
Oral, with or without food
Dosage
Hypertension: 2.5mg once daily, titrate to 5-10mg; Post-MI: 2.5mg twice daily, increase to 5mg twice daily; Heart failure: 2.5-5mg twice daily
Indications
Hypertension, chronic heart failure, post-MI left ventricular dysfunction, cardiovascular risk reduction, diabetic and non-diabetic nephropathy
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 25°C, protected from moisture
Shelf Life
36 months
Side Effects
Dry cough (up to 10-15%), dizziness, hypotension, hyperkalemia, angioedema (rare but serious), elevated creatinine
Precautions
Contraindicated in pregnancy; risk of angioedema; monitor renal function and potassium; avoid NSAIDs; first-dose hypotension risk in volume-depleted patients; contraindicated with aliskiren in diabetics

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Metoprolol Succinate 50mgTablet

Metoprolol Succinate 50mg

Metoprolol Succinate

Cardioselective beta-1 adrenoceptor blocker in extended-release formulation that reduces heart rate, blood pressure, and myocardial oxygen demand with once-daily dosing for hypertension, stable angina, and heart failure with reduced ejection fraction. Manufactured to USP standards by Sun Pharma and Cipla and exported globally as a key cardiovascular agent in hypertension, post-MI, and heart failure management protocols.

25mg / 50mg / 100mg
Losartan 50mgTablet

Losartan 50mg

Losartan Potassium

Selective AT1 angiotensin II receptor blocker (ARB) that reduces blood pressure, protects renal function in diabetic nephropathy, and decreases cardiovascular events in hypertensive patients with left ventricular hypertrophy, with a tolerability advantage over ACE inhibitors due to the absence of bradykinin-mediated cough. Manufactured by Cipla and Sun Pharma and exported globally as a widely-used first-line antihypertensive and renoprotective agent.

25mg / 50mg / 100mg
Warfarin 5mgTablet

Warfarin 5mg

Warfarin Sodium

Vitamin K antagonist oral anticoagulant that prevents thromboembolic events by inhibiting hepatic synthesis of clotting factors II, VII, IX, and X, remaining the standard of care for mechanical heart valves and widely used in atrial fibrillation and VTE treatment worldwide. Supplied in multiple low-dose strengths from Sun Pharma and Cipla to allow fine INR titration, exported for anticoagulation clinics and hospital cardiology departments globally.

1mg / 2mg / 2.5mg / 5mg

Need bulk pricing for Ramipril 5mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote